Wynnewood, PA, United States of America

Yoshimasa Ito

This inventor holds 1 USPTO granted patent. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshimasa Ito. Retrieved from https://idiyas.com/inventor/yoshimasa-ito-lvc6nf80

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yoshimasa Ito

Introduction

Yoshimasa Ito is a notable inventor based in Wynnewood, PA (US). He has made significant contributions to the field of medical treatments, particularly in the area of epilepsy. His innovative approach combines various chemical agents to create effective therapeutic solutions.

Latest Patents

Yoshimasa Ito holds a patent for an epilepsy treatment agent. This patent involves a combination agent that merges N-[(1S)-2,2,5,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfamide with an AMPA-type glutamate receptor antagonist. The potential therapeutic applications of this combination agent are promising for individuals suffering from epilepsy. He has 1 patent to his name.

Career Highlights

Ito is associated with Eisai R&D Management Co., Ltd., where he continues to work on innovative solutions for medical challenges. His research focuses on developing effective treatments that can improve the quality of life for patients with neurological disorders.

Collaborations

Throughout his career, Yoshimasa Ito has collaborated with esteemed colleagues such as Hiroyuki Higashiyama and Hisashi Wakita. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.

Conclusion

Yoshimasa Ito's contributions to epilepsy treatment exemplify the impact of innovative thinking in the medical field. His work continues to inspire advancements that may lead to better health outcomes for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…